These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Subsets of T cells in myeloma, macroglobulinemia and benign monoclonal gammopathy: analysis of surface markers defined by monoclonal antibodies and the effect on Ig-synthesis by B cells]. Okagawa K; Iguchi K; Iishi Y; Kosaka M Nihon Ketsueki Gakkai Zasshi; 1985 Aug; 48(5):1205-13. PubMed ID: 3934898 [No Abstract] [Full Text] [Related]
6. Current concepts on monoclonal gammopathies. Kyle RA Aust N Z J Med; 1992 Jun; 22(3):291-302. PubMed ID: 1497556 [TBL] [Abstract][Full Text] [Related]
7. Imbalances of T-cell subsets in monoclonal gammopathies. Bergmann L; Mitrou PS; Weber KC; Kelker W Cancer Immunol Immunother; 1984; 17(2):112-6. PubMed ID: 6331877 [TBL] [Abstract][Full Text] [Related]
8. Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance. Pilarski LM; Andrews EJ; Serra HM; Ledbetter JA; Ruether BA; Mant MJ Am J Hematol; 1989 Feb; 30(2):53-60. PubMed ID: 2536515 [TBL] [Abstract][Full Text] [Related]
9. When a Monoclonal Gammopathy Is Not Multiple Myeloma. Derman B; Castillo JJ; Sarosiek S; Beksac M Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-10. PubMed ID: 35394823 [TBL] [Abstract][Full Text] [Related]
10. M protein idiotype in patients with monoclonal gammopathies. Sugai S; Shimizu S; Konda S Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1749-56. PubMed ID: 3105208 [No Abstract] [Full Text] [Related]
11. Monoclonal antibody-defined T lymphocyte subpopulations in monoclonal gammapathy of undetermined significance. Cunietti E; Galli M; Ottomano C; Negri C; Soldini L; Scapellato L; Sensalari G Ric Clin Lab; 1987; 17(4):301-8. PubMed ID: 3501877 [TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders. Morra E; Cesana C; Klersy C; Barbarano L; Varettoni M; Cavanna L; Canesi B; Tresoldi E; Miqueleiz S; Bernuzzi P; Nosari AM; Lazzarino M Leukemia; 2004 Sep; 18(9):1512-7. PubMed ID: 15322559 [TBL] [Abstract][Full Text] [Related]
13. [The OKT4/OKT8 ratio in benign monoclonal gammopathies]. La Rosa L; Mattoni C; La Rosa M Minerva Med; 1988 Dec; 79(12):1049-50. PubMed ID: 2974933 [TBL] [Abstract][Full Text] [Related]
14. T-cell subsets defined by monoclonal antibodies in monoclonal gammopathy of undetermined significance (MGUS). Cavanna L; Di Stasi M; Fornari F; Civardi G; Binelli F; Buscarini E; Buscarini L Tumori; 1985 Dec; 71(6):543-6. PubMed ID: 2934880 [TBL] [Abstract][Full Text] [Related]
15. [Epidemiology of monoclonal gammopathies]. Hurez D Rev Prat; 1993 Feb; 43(3):271-4. PubMed ID: 8502953 [TBL] [Abstract][Full Text] [Related]
16. Myeloma and macroglobulinemia: what are the criteria for diagnosis? Stone MJ Clin Lymphoma; 2002 Jun; 3(1):23-5. PubMed ID: 12141951 [TBL] [Abstract][Full Text] [Related]
17. [Neurologic manifestations of monoclonal gammapathies]. Uldry PA; Steck AJ; Regli F Schweiz Med Wochenschr; 1984 Nov; 114(47):1678-85. PubMed ID: 6096963 [TBL] [Abstract][Full Text] [Related]
18. Comparative study of immune status to infectious agents in elderly patients with multiple myeloma, Waldenstrom's macroglobulinemia, and monoclonal gammopathy of undetermined significance. Karlsson J; Andréasson B; Kondori N; Erman E; Riesbeck K; Hogevik H; Wennerås C Clin Vaccine Immunol; 2011 Jun; 18(6):969-77. PubMed ID: 21508164 [TBL] [Abstract][Full Text] [Related]